Neuland Laboratories shares decline 5% after Q2 results see revenue drop and margin contraction

https://www.cnbctv18.com/market/neuland-laboratories-share-price-q2-result-reaction-peptide-cdmo-business-volatile-numbers-execution-plans-margins-outlook-20026469.htm
Neuland Laboratories’ margins in the September quarter contracted to 24.1% from 30.2% in the year-ago period and from 34.7% in the prior quarter…